peptidyl-prolyl isomerase inhibitors (Encycle Therapeutics)

N/A

Report date: 2025/03/20 09:52:06
NME

Base Information

Drug Namepeptidyl-prolyl isomerase inhibitors (Encycle Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidylprolyl isomerase inhibitors
TargetsPeptidylprolyl isomerase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEncycle Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEncycle Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A